Results 151 to 160 of about 5,496 (285)

The Place of Cannabinoids in the Treatment of Gynecological Pain. [PDF]

Drugs, 2023
Sinclair J, Abbott J, Proudfoot A, Armour M.   +3 more
europepmc   +1 more source

A call for action: Closing the evidence gap in management of stimulant‐induced psychosis

Addiction, EarlyView.
Abstract Background Stimulant‐induced psychosis (StIP) is emerging as one of most pressing health challenges. Over the past two decades, stimulant‐related harms and psychiatric care demands have risen sharply. Individuals with StIP often present with severe agitation and high suicide risk, and up to half progress to chronic psychotic illness within two
Anne Bouthillier, Heidar Sharafi, Adam Bisaga, Didier Jutras‐Aswad   +3 more
wiley   +1 more source

Sleep quality of adult recreational cannabis users: a systematic review of literature. [PDF]

Trends Psychiatry Psychother
Costa NL, Silva WCDSE, Silva MLD, Cunha KDC.   +3 more
europepmc   +1 more source

Cannabis in medicine: a national educational needs assessment among Canadian physicians [PDF]

, 2015

core   +1 more source

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis

Addiction, EarlyView.
Abstract Aim To monitor community‐level consumption of 20 illicit drugs across urban areas of England using wastewater‐based epidemiology (WBE) surveillance at high temporal resolution. Design, setting, cases This study was conducted over a 12‐month period in 2022 sampling 24‐hour composite wastewater samples at 15 wastewater treatment plants (WWTPs ...
Helena Rapp‐Wright, Keng Tiong Ng, Derryn Grant, William Francis, Margarita White, Dimitris Evangelopoulos, Yuxing Liu, Konstantina Dimakopoulou, Sofia Zafeiratou, Dylan Wood, Chryshanthi Christy, Stav Friedman, Timothy W. Gant, Klea Katsouyanni, Leon P. Barron   +14 more
wiley   +1 more source

Bibliometric analysis of beneficial cannabis research: Performance analysis and science mapping from 2012 to 2022 and focus on Morocco. [PDF]

Toxicol Rep
Laaboudi FZ, Rejdali M, Salhi A, Elyoussfi A, Talhaoui A, Amhamdi H, Ahari M.   +6 more
europepmc   +1 more source

Lessons from 20 years of medical cannabis use in Canada. [PDF]

PLoS One, 2023
Shim M, Nguyen H, Grootendorst P.
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Daily patterns of substance use among young adults who vape nicotine and cannabis: Latent class analysis of smartphone-based daily diary data. [PDF]

Drug Alcohol Depend
Halliday DM, Lund L, Ling PM, Nguyen N.
europepmc   +1 more source

Passive Prenatal Exposure to Cannabinoids Promotes Weight Gain and Dysglycemia in Childhood.

J Clin Endocrinol Metab, 2022
Rosenbaum M.
europepmc   +1 more source